Sign in
Create a Profile
Duloxetine for the Treatment of Postpartum Depression
Diseases and Conditions Researched
Major Depressive Disorder; Postpartum Depression
What is the purpose of this trial?
The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.
Participation Guidelines
Gender: Female
Click here for detailed participation information for this trial.
| Sponsor: | Yale University |
|---|---|
| Dates: | February 4, 2008 |
| Last Updated: | August 7, 2012 |
| Study HIC#: | 0609001827 |
| Clinicaltrials.gov ID: | NCT00617045 |
How will my information be used?
For more information about this trial, contact:
Heather Howell, MSW, LCSW
764-6764
Principal Investigator
Yonkers, Kimberly Ann
Psychiatry
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
